VTRS · News · 20261112N

Acquisition / Partnership / Divestiture

Viatris Inc · 2026-11-12 · Importance 60 · Surprise 48

Viatris is pursuing the acquisition of Pacira BioSciences through wholly owned subsidiary Peach Purchaser Sub Inc. The tender offer is US$36.50 per Pacira share in cash, and the deal was described in third-party reporting as a planned US$1.65 billion purchase. The acquisition was pending final closing conditions in reporting dated November 12, 2026. Viatris said it intends to vigorously defend against two Pacira stockholder complaints seeking to block the merger or obtain damages over alleged omissions in merger disclosures.

Key facts